FIRM REPRESENTED BLUE CHIP CLIENTS IN MERGERS AND ACQUISITIONS, ASSET PURCHASES AND STOCK PURCHASES
January 31, 2019
Pepper Hamilton LLP today announced results of the deals closed during the 2018 calendar year. The firm advised on more than 90 deals, with combined transaction values exceeding $10.5 billion, including cross-border deals in the United Kingdom, Canada and Turkey. The firm closed out the year strong, with Q4 bringing the highest number of overall deals as well as the highest total dollar value for deals.
Pepper Hamilton partners provided counsel to organizations across a variety of industries, including pharmaceutical, life sciences, medical devices, energy and utilities, insurance, software, manufacturing, technology, construction, financial services and more.
“2018 was a top-notch year for deal execution, with our attorneys bringing unparalleled market knowledge to the table and providing unmatched client service,” said Matthew Greenberg, chair of the Corporate and Securities Practice Group at Pepper Hamilton. “Our Corporate and Securities group consistently closed more than a dozen deals each quarter, providing our clients with innovative solutions for today’s marketplace.”
The firm’s Health Sciences Department also experienced a strong finish for the year, closing more than $1.1 billion in deals during Q4 alone.
“In today’s ever-evolving health sciences ecosystem, our clients need attorneys who deeply understand the complexities of the health care and life sciences industries,” said Rachael Bushey, vice chair of the Health Sciences Department and chair of Life Sciences at Pepper Hamilton. “In such highly regulated fields, these deals can pose significant risks if not structured properly. Our team helps clients expertly navigate these potential risks and structure deals in compliance with regulations, ensuring clients achieve their desired outcome. Our Q4 results, in particular, are a testament to this commitment.”
Roughly half of the deals closed by Pepper Hamilton in 2018 were private equity-related, which remained consistent per quarter.
“We are encouraged by the consistently strong performance of private equity-related deals throughout the year,” said Bruce Fenton, chair of the Private Equity Practice Group at Pepper Hamilton. “We are seeing deal activity remaining steady as we start 2019.”
Compliments of Pepper Hamilton, a member of the EACCNY